{
    "classes": [
        "SOFTNAME",
        "SOFTVERS",
        "STIME",
        "MOL",
        "FFM",
        "TEMP"
    ],
    "raw_text": "Glycosylated Swiss-model molecular dynamics trajectory of SARS-CoV-2 spike glycoprotein\nMolecular dynamics simulation trajectory. The system is the SARS-CoV-2 spike glycoprotein with glycans modeled on using GLYCAM-Web. SARS-CoV2 spike (S) protein structure A 3D structure of the prefusion form of the S protein (RefSeq: YP 009724390.1, UniProt: P0DTC2 SPIKE SARS2), based on a Cryo-EM structure (PDB code 6VSB), was obtained from the SWISS-MODEL server (swissmodel.expasy.org). The model has 95% coverage (residues 27 to 1146) of the S protein. The site specific glycans used to model a glycoform representative of the data obtained from the S glycoprotein expressed in HEK293 cells, are presented below: Hybrid: DManp 1-6[DManp 1-3]DManp 1-6[DGlcpNAc 1-2DManp 1-3]DManp 1-4DGlcpNAc 1-4DGlcpNAc 1-OH Glycosites: 657 FA2: DGlcpNAc 1-2DManp 1-6[DGlcpNAc 1-2DManp 1-3]DManp 1-4DGlcpNAc 1-4[LFucp 1-6]DGlcpNAc 1-OH Glycosites: 149, 165, 331, 343, 616, 1134 A2: DGlcpNAc 1-2DManp 1-6[DGlcpNAc 1-2DManp 1-3]DManp 1-4DGlcpNAc 1-4DGlcpNAc 1-OH Glycosites: 1098 FA2B: DGlcpNAc 1-2DManp 1-6[DGlcpNAc 1-4][DGlcpNAc 1-2DManp 1-3]DManp 1-4DGlcpNAc 1-4[LFucp 1-6]DGlcpNAc 1-OH Glycosites: 74, 282 M5: DManp 1-6[DManp 1-3]DManp 1-6[DManp 1-3]DManp 1-4DGlcpNAc 1-4DGlcpNAc 1-OH Glycosites: 61, 122, 603, 709, 717, 801, 1074 M8: DManp 1-2DManp 1-6[DManp 1-2DManp 1-3]DManp 1-6[DManp 1-2DManp 1-3]DManp 1-4DGlcpNAc 1-4DGlcpNAc 1-OH Glycosites: 234 Glycan naming system. In cases where the mass spectrometry data allows for multiple structures, such as FA2/FA1B, the glycan with the least ambiguity was selected. For example, FA2 was selected over FA1B, as the position of the single antennae is ambiguous.Dataset supports the following preprint: 3D Models of glycosylated SARS-CoV-2 spike protein suggest challenges and opportunities for vaccine development. Oliver C. Grant, David Montgomery, Keigo Ito, Robert J. Woods; bioRxiv 2020.04.07.030445; doi: https://doi.org/10.1101/2020.04.07.030445",
    "entities": [
        {
            "label": "SOFTNAME",
            "text": "Swiss-model",
            "start": 13,
            "end": 24
        },
        {
            "label": "MOL",
            "text": "SARS-CoV-2 spike",
            "start": 58,
            "end": 74
        },
        {
            "label": "MOL",
            "text": "glycoprotein",
            "start": 75,
            "end": 87
        },
        {
            "label": "MOL",
            "text": "SARS-CoV-2 spike",
            "start": 148,
            "end": 164
        },
        {
            "label": "MOL",
            "text": "glycoprotein",
            "start": 165,
            "end": 177
        },
        {
            "label": "MOL",
            "text": "glycans",
            "start": 183,
            "end": 190
        },
        {
            "label": "SOFTNAME",
            "text": "GLYCAM-Web",
            "start": 208,
            "end": 218
        },
        {
            "label": "MOL",
            "text": "SARS-CoV2 spike",
            "start": 220,
            "end": 235
        },
        {
            "label": "MOL",
            "text": "S",
            "start": 237,
            "end": 238
        },
        {
            "label": "MOL",
            "text": "S",
            "start": 302,
            "end": 303
        },
        {
            "label": "MOL",
            "text": "P0DTC2",
            "start": 346,
            "end": 352
        },
        {
            "label": "MOL",
            "text": "SPIKE SARS2",
            "start": 353,
            "end": 364
        },
        {
            "label": "MOL",
            "text": "6VSB",
            "start": 406,
            "end": 410
        },
        {
            "label": "SOFTNAME",
            "text": "SWISS-MODEL",
            "start": 435,
            "end": 446
        },
        {
            "label": "MOL",
            "text": "S",
            "start": 535,
            "end": 536
        },
        {
            "label": "MOL",
            "text": "glycans",
            "start": 564,
            "end": 571
        },
        {
            "label": "MOL",
            "text": "S",
            "start": 643,
            "end": 644
        },
        {
            "label": "MOL",
            "text": "glycoprotein",
            "start": 645,
            "end": 657
        },
        {
            "label": "MOL",
            "text": "FA2",
            "start": 817,
            "end": 820
        },
        {
            "label": "MOL",
            "text": "FA2B",
            "start": 1054,
            "end": 1058
        },
        {
            "label": "MOL",
            "text": "Glycan",
            "start": 1431,
            "end": 1437
        },
        {
            "label": "MOL",
            "text": "FA2",
            "start": 1535,
            "end": 1538
        },
        {
            "label": "MOL",
            "text": "FA1B",
            "start": 1539,
            "end": 1543
        },
        {
            "label": "MOL",
            "text": "glycan",
            "start": 1549,
            "end": 1555
        },
        {
            "label": "MOL",
            "text": "FA2",
            "start": 1608,
            "end": 1611
        },
        {
            "label": "MOL",
            "text": "FA1B",
            "start": 1630,
            "end": 1634
        },
        {
            "label": "MOL",
            "text": "SARS-CoV-2 spike",
            "start": 1755,
            "end": 1771
        },
        {
            "label": "MOL",
            "text": "protein",
            "start": 1772,
            "end": 1779
        }
    ]
}